Hong Kong, Macau suspends BioNTech vaccines for packaging defects

Hong Kong and Macau have temporarily suspended Covid vaccines manufactured by BioNTech SE due to a packaging defect, hitting cities’ efforts to revive their pandemic economies.

Both governments said on Wednesday that they had received notifications about defects in the packaging of the bottle. Shanghai Fosun Pharmaceutical Group Co., which has the rights to develop and market the photos in mainland China, Hong Kong, Macao and Taiwan. BioNTech and Fosun Pharma have launched an investigation into the problem and say there is no reason to believe that product safety is in jeopardy, according to a statement from the Macau government.

Hong Kong suspends BioNTech vaccines for packaging defect

A community vaccination center that administers BioNTech Covid-19 is temporarily closed on March 24.

Photographer: Kyle Lam / Bloomberg

The suspension marks the latest failure to launch the vaccine in Hong Kong, which has been slowed by public distrust of the Beijing-backed government. While the takeover of the BioNTech jab had begun to surpass that of the photos taken by the Chinese company Sinovac Biotech Ltd., concerns about packaging defects risk eroding public confidence in both options.

.Source